Low-dose aspirin may slow growth of colon, pancreatic cancer cells

By Amanda Gibbs January 19, 2017 Portland, Ore.

Downloads

(Left to right) Technician JP Pang, Owen McCarty, Ph.D., a professor in the Department of Biomedical Engineering at OHSU, and Annachiara Mitrugno, Ph.D., a postdoctoral fellow in the Division of Hematology and Medical Oncology at OHSU, have published research revealing low doses of aspirin might eventually prove safe and effective for some types of cancer prevention. (OHSU)

Aspirin cancer prevention

First author Annachiara Mitrugno, Ph.D., a postdoctoral fellow in the Division of Hematology and Medical Oncology at OHSU, designed the project and performed much of the research. (OHSU)